Volver a Agenda
Session Chair(s)
Gesine Bejeuhr, PHARMD
Pediatric Regulatory Leader
Bayer AG, Germany
Learning Objective : Describe results of the collaboration between the DIA Pediatric Community and Bayesian and Adaptive Design Scientific Working Groups; Examine potential applications of Bayesian methods and adaptive designs to improve pediatric medical product development; Identify opportunities to collaborate on application of novel approaches in pediatric designs via open discussion and case examples; Provide information to prepare the right messages to patients, investigators, and industry decision-makers.
Speaker(s)
Bayesian Statistics and Adaptive Design
Scott Berry, PHD
Berry Consultants LLC, United States
President and Senior Statistical Scientist
Pediatric Studies and Bayesian Statistics: Challenges and Opportunities
Freda Cooner, PHD
FDA, United States
Statistician
Pharmaceutical Company Perspective
Brenda Cirincione, PHD, MS
Vertex, United States
Vice President, Clinical and Quantitative Pharmacology
¿Tiene una cuenta?